Response to D. Woolf and M. Keshtgar's reply to: Breast Radiotherapy and Heart Disease - Where Are We Now?

摘要

Sir-We thank Woolf and Keshtgar [1 ] for their response to our editorial [2]. In keeping with other partial breast radiotherapy techniques, intraoperative radiotherapy may offer heart-sparing benefits, and dosimetric data to support this would be welcomed. As Woolf and Keshtgar point out, whole breast radiotherapy remains the current UK standard. However, partial breast irradiation may have a role to play in the treatment of patients at low risk of recurrence, and the long-term results of a number of partial breast radiotherapy trials are awaited with interest.